{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T21:46:05Z","timestamp":1648935965527},"posted":{"date-parts":[[2017,10,6]]},"reference-count":0,"publisher":"Morressier","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.26226\/morressier.59a3edabd462b8028d895091","type":"posted-content","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T10:29:40Z","timestamp":1582108180000},"source":"Crossref","is-referenced-by-count":0,"title":["Accessing early neurodegeneration in multiple sclerosis: biomarkers for diagnostics and phenotypic characterization"],"prefix":"10.26226","author":[{"given":"Lenka","family":"Novakova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22980","container-title":[],"original-title":[],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T11:00:28Z","timestamp":1582110028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.morressier.com\/article\/59a3edabd462b8028d895091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.26226\/morressier.59a3edabd462b8028d895091","relation":{},"subject":[],"published":{"date-parts":[[2017,10,6]]},"subtype":"other"}}